BioNTech and its U.S. partner Pfizer have already begun manufacturing Covid-19 boosters that are adapted for multiple Omicron ...

BioNTech and Pfizer announced trials this month for their adapted COVID-19 vaccines, to fight faster-spreading Omicron ...

Most older U.S. adults are prepared to roll up their sleeves to get an updated COVID-19 booster shot once one becomes ...

BioNTech, with its partner Pfizer, expects to begin deliveries of two omicron-adapted vaccines as soon as October in time for ...

Two Pfizer and BioNTech Covid-19 vaccine boosters updated to target the Omicron variant show a substantially higher immune response than the current Covid-19 vaccine, the companies said Saturday.

The small-scale study is part of the companies’ efforts to update their vaccine in time for a potential fall vaccination ...

The Biden administration plans to begin a COVID-19 booster campaign with reformulated vaccines in September. The new boosters ...

Pharmaceutical and biotechnology companies Pfizer and BioNTech announced Saturday that updated versions of their ... Studies “found that a booster dose of both Omicron-adapted vaccine candidates ...

BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth quarter, the German biotech firm said on Monday as it reaffirmed its ...

This is the first of multiple vaccine candidates with an enhanced design which the companies plan to evaluate as part of a long-term scientific COVID-19 vaccine strategy to potentially generate more ...

NEW YORK — Pfizer Inc and BioNTech SE said on Saturday that a booster dose of updated versions of their COVID-19 vaccine, modified specifically to combat the Omicron coronavirus variant, generated a ...

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind Phase ...